Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dr Reddys Laboratories (RDY) EPS (Weighted Average and Diluted) (2016 - 2023)

Historic EPS (Weighted Average and Diluted) for Dr Reddys Laboratories (RDY) over the last 15 years, with Q2 2023 value amounting to $1.94.

  • Dr Reddys Laboratories' EPS (Weighted Average and Diluted) fell 1573.92% to $1.94 in Q2 2023 from the same period last year, while for Jun 2023 it was $1.94, marking a year-over-year decrease of 1573.92%. This contributed to the annual value of $0.79 for FY2025, which is 8029.93% down from last year.
  • As of Q2 2023, Dr Reddys Laboratories' EPS (Weighted Average and Diluted) stood at $1.94, which was down 1573.92% from $164.95 recorded in Q1 2023.
  • In the past 5 years, Dr Reddys Laboratories' EPS (Weighted Average and Diluted) ranged from a high of $187.76 in Q3 2020 and a low of -$183.4 during Q3 2019
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $159.95 (2019), whereas its average is $106.63.
  • Over the last 5 years, Dr Reddys Laboratories' EPS (Weighted Average and Diluted) had its largest YoY gain of 710913.81% in 2019, and its largest YoY loss of 20919.26% in 2019.
  • Over the past 5 years, Dr Reddys Laboratories' EPS (Weighted Average and Diluted) (Quarter) stood at $157.97 in 2019, then dropped by 23.79% to $120.39 in 2020, then surged by 30.15% to $156.69 in 2021, then crashed by 98.71% to $2.03 in 2022, then dropped by 4.32% to $1.94 in 2023.
  • Its last three reported values are $1.94 in Q2 2023, $164.95 for Q1 2023, and $2.03 during Q4 2022.